{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T12:47:17Z","timestamp":1784810837916,"version":"3.55.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.taap.2012.03.001","type":"journal-article","created":{"date-parts":[[2012,3,9]],"date-time":"2012-03-09T12:03:37Z","timestamp":1331294617000},"page":"209-221","source":"Crossref","is-referenced-by-count":41,"title":["Characterization and validation of an in silico toxicology model to predict the mutagenic potential of drug impurities*"],"prefix":"10.1016","volume":"260","author":[{"suffix":"Jr.","given":"Luis G.","family":"Valerio,","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin P.","family":"Cross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2012.03.001_bb0005","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0165-1218(86)90078-9","article-title":"Ames Salmonella\/Mammalian-microsome testing of peptides and peptide synthesis reagents","volume":"170","author":"Allen","year":"1986","journal-title":"Mutat. Res."},{"key":"10.1016\/j.taap.2012.03.001_bb0010","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0165-1218(88)90114-0","article-title":"Chemical structure, Salmonella mutagenicity and extent of carcinogenicity as indicators of genotoxic carcinogenesis among 222 chemicals tested in rodents by the U.S. NCI\/NTP","volume":"204","author":"Ashby","year":"1988","journal-title":"Mutat. Res."},{"key":"10.1016\/j.taap.2012.03.001_bb0015","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0165-1218(89)90037-2","article-title":"Classification according to chemical structure, mutagenicity to Salmonella and level of carcinogenicity of a further 42 chemicals tested for carcinogenicity by the U.S. National Toxicology Program","volume":"223","author":"Ashby","year":"1989","journal-title":"Mutat. Res."},{"key":"10.1016\/j.taap.2012.03.001_bb0020","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.yrtph.2005.04.006","article-title":"The use of structure\u2013activity relationship analysis in the food contact notification program","volume":"42","author":"Bailey","year":"2005","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.taap.2012.03.001_bb0030","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.mrrev.2008.05.003","article-title":"Structure alerts for carcinogenicity, and the Salmonella assay system: a novel insight through the chemical relational databases technology","volume":"659","author":"Benigni","year":"2008","journal-title":"Mutat. Res."},{"issue":"4","key":"10.1016\/j.taap.2012.03.001_bb0035","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1021\/cr100222q","article-title":"Mechanisms of Chemical Carcinogenicity and Mutagenicity: A Review with Implications for Predictive Toxicology","volume":"111","author":"Benigni","year":"2011","journal-title":"Chem. Rev."},{"key":"10.1016\/j.taap.2012.03.001_bb0025","unstructured":"Benigni R, Bossi C, Jeliazkova N, Netzeva T, and Worth A, (2008). The Benigni \/ Bossa rulebase for mutagenicity and carcinogenicity - a module of Toxtree. In JRC Scientific and Technical Reports. (J. R. C. European Commission, Ed.), pp. 1\u201378. European Chemicals Bureau, Institute for Health & Consumer Protection, Ispra, Italy."},{"key":"10.1016\/j.taap.2012.03.001_bb0040","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1021\/ci900378x","article-title":"An in silico method for predicting Ames activities of primary aromatic amines by calculating the stabilities of nitrenium ions","volume":"50","author":"Bentzien","year":"2010","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.taap.2012.03.001_bb0045","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1517\/17425255.2011.602066","article-title":"Challenges for computational structure\u2013activity modelling for predicting chemical toxicity: future improvements?","volume":"7","author":"Combes","year":"2011","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.taap.2012.03.001_bb0050","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.yrtph.2010.09.016","article-title":"Improved in silico prediction of carcinogenic potency (TD50) and the risk specific dose (RSD) adjusted Threshold of Toxicological Concern (TTC) for genotoxic chemicals and pharmaceutical impurities","volume":"59","author":"Contrera","year":"2011","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.taap.2012.03.001_bb0055","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.yrtph.2005.09.001","article-title":"In silico screening of chemicals for bacterial mutagenicity using electrotopological E-state indices and MDL QSAR software","volume":"43","author":"Contrera","year":"2005","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.taap.2012.03.001_bb0060","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/15376510701857106","article-title":"In Silico Screening of Chemicals for Genetic Toxicity Using MDL-QSAR, Nonparametric Discriminant Analysis, E-State, Connectivity, and Molecular Property Descriptors","volume":"18","author":"Contrera","year":"2008","journal-title":"Toxicol. Mech. Methods"},{"key":"10.1016\/j.taap.2012.03.001_bb0065","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/bjc.1979.10","article-title":"Describing the validity of carcinogen screening tests","volume":"39","author":"Cooper","year":"1979","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.taap.2012.03.001_bb0070","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0015-6264(76)80522-6","article-title":"Estimation of toxic hazard\u2013a decision tree approach","volume":"16","author":"Cramer","year":"1978","journal-title":"Food Cosmet Toxicol."},{"key":"10.1016\/j.taap.2012.03.001_bb0075","author":"DIA"},{"key":"10.1016\/j.taap.2012.03.001_bb0080","series-title":"DIA\/FDA Quantitative Structure Activity Relationship Analysis (Q)SAR Approaches to Assessing Genotoxic Impurities in Pharmaceuticals","article-title":"Case Studies Introduction. An Overview of Industry Experience in Conducting In Silico Analysis","author":"Dobo","year":"2011"},{"key":"10.1016\/j.taap.2012.03.001_bb0085","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.yrtph.2006.01.004","article-title":"The application of structure-based assessment to support safety and chemistry diligence to manage genotoxic impurities in active pharmaceutical ingredients during drug development","volume":"44","author":"Dobo","year":"2006","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.taap.2012.03.001_bb0090","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1021\/tx8004339","article-title":"A Strategy for the Risk Assessment of Human Genotoxic Metabolites","volume":"22","author":"Dobo","year":"2009","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.taap.2012.03.001_bb0095","doi-asserted-by":"crossref","first-page":"728","DOI":"10.3109\/10408444.2010.494175","article-title":"A review of the electrophilic reaction chemistry involved in covalent DNA binding","volume":"40","author":"Enoch","year":"2010","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.taap.2012.03.001_bb0100","unstructured":"FDA (1997). Guidance for Industry. Q3C Impurities: Residual Solvents. (Department of Health and Human Services, Ed.), pp. 1\u201316. FDA CDER and CBER, Rockville, MD USA."},{"key":"10.1016\/j.taap.2012.03.001_bb0105","unstructured":"FDA (2006). Guidance for Industry. Q3B(R2) Impurities in New Drug Products. (Department of Health and Human Services, Ed.), pp. 1\u201318. FDA CDER and CBER, Rockville, MD USA."},{"key":"10.1016\/j.taap.2012.03.001_bb0110","unstructured":"FDA (2008a). Guidance for Industry. Q3A Impurities in New Drug Substances. (Department of Health and Human. Services, Ed.), pp. 1\u201317. FDA CDER and CBER, Rockville, MD USA."},{"key":"10.1016\/j.taap.2012.03.001_bb0115","unstructured":"FDA (2008b). Guidance for Industry. Genotoxic and Carcinogenic Impurities in Drug Substances and Products: Recommended Approaches. Draft Guidance. (U. S. Department of Health and Human Services, Ed.), pp. 1\u201313. Office of Communications, Division of Drug Information, CDER, FDA. Rockville, MD."},{"key":"10.1016\/j.taap.2012.03.001_bb0120","author":"FDA"},{"key":"10.1016\/j.taap.2012.03.001_bb0125","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1021\/jm040835a","article-title":"Derivation and validation of toxicophores for mutagenicity prediction","volume":"48","author":"Kazius","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.taap.2012.03.001_bb0130","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.yrtph.2007.01.006","article-title":"An evaluation of the sensitivity of the Ames assay to discern low-level mutagenic impurities","volume":"48","author":"Kenyon","year":"2007","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.taap.2012.03.001_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18388\/abp.1994_4766","article-title":"Characterization of the genotoxic properties of nitrofurans: nitrofurazone and furazolidone","volume":"41","author":"Kobierska-Szeliga","year":"1994","journal-title":"Acta Biochim. Pol."},{"key":"10.1016\/j.taap.2012.03.001_bb0140","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0278-6915(99)00120-9","article-title":"Threshold of toxicological concern for chemical substances present in the diet: a practical tool for assessing the need for toxicity testing","volume":"38","author":"Kroes","year":"2000","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.taap.2012.03.001_bb0145","unstructured":"Leadscope (2010). Leadscope\/FDA SAR Gentox Database Documentation. In Documentation of Leadscope\/FDA CRADA SAR Genetox Database. (L. Inc., Ed.), pp. 1\u201327. Leadscope Inc., Columbus, OH USA."},{"key":"10.1016\/j.taap.2012.03.001_bb0150","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/15376510701857320","article-title":"In silico tools for sharing data and knowledge on toxicity and metabolism: derek for windows, meteor, and vitic","volume":"18","author":"Marchant","year":"2008","journal-title":"Toxicol. Mech. Methods"},{"key":"10.1016\/j.taap.2012.03.001_bb0155","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.yrtph.2005.11.003","article-title":"An analysis of genetic toxicity, reproductive and developmental toxicity, and carcinogenicity data: I. Identification of carcinogens using surrogate endpoints","volume":"44","author":"Matthews","year":"2006","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.taap.2012.03.001_bb0160","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.yrtph.2005.10.004","article-title":"An analysis of genetic toxicity, reproductive and developmental toxicity, and carcinogenicity data: II. Identification of genotoxicants, reprotoxicants, and carcinogens using in silico methods","volume":"44","author":"Matthews","year":"2006","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.taap.2012.03.001_bb0165","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1517\/17425255.2010.489551","article-title":"Computational toxicology at the European commission's joint research centre","volume":"6","author":"Mostrag-Szlichtyng","year":"2010","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.taap.2012.03.001_bb0170","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1517\/17425255.2010.489551","article-title":"Computational toxicology at the European Commission's Joint Research Centre","volume":"6","author":"Mostrag-Szlichtyng","year":"2010","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.taap.2012.03.001_bb0175","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1517\/17425255.2010.495118","article-title":"The computational prediction of genotoxicity","volume":"6","author":"Naven","year":"2010","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.taap.2012.03.001_bb0180","author":"NLM. National Library of Medicine"},{"key":"10.1016\/j.taap.2012.03.001_bb0185","series-title":"Toxicity Testing in the 21st Century: A Vision and a Strategy","author":"NRC","year":"2007"},{"key":"10.1016\/j.taap.2012.03.001_bb0190","unstructured":"OECD (2004). The report from the expert group on (quantitative) structure\u2013activity relationship ([Q]SAR) on the principals for the validation of [Q]SARs. (O. F. E. C. A. Development, Ed.). OECD, Paris."},{"key":"10.1016\/j.taap.2012.03.001_bb0195","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/em.20485","article-title":"An update on the genotoxicity and carcinogenicity of marketed pharmaceuticals with reference to in silico predictivity","volume":"50","author":"Snyder","year":"2009","journal-title":"Environ. Mol. Mutagen."},{"key":"10.1016\/j.taap.2012.03.001_bb0200","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/em.20013","article-title":"Assessment of the sensitivity of the computational programs DEREK, TOPKAT, and MCASE in the prediction of the genotoxicity of pharmaceutical molecules","volume":"43","author":"Snyder","year":"2004","journal-title":"Environ. Mol. Mutagen."},{"key":"10.1016\/j.taap.2012.03.001_bb0205","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0165-1110(91)90002-D","article-title":"Classification according to chemical structure, mutagenicity to Salmonella and level of carcinogenicity of a further 39 chemicals tested for carcinogenicity by the U.S. National Toxicology Program","volume":"257","author":"Tennant","year":"1991","journal-title":"Mutat. Res."},{"key":"10.1016\/j.taap.2012.03.001_bb0210","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.taap.2009.08.022","article-title":"In silico toxicology for the pharmaceutical sciences","volume":"241","author":"Valerio","year":"2009","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2012.03.001_bb0215","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1517\/17425255.2010.486789","article-title":"Computational science in drug metabolism and toxicology","volume":"6","author":"Valerio","year":"2010","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.taap.2012.03.001_bb0220","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1517\/17425250903499286","article-title":"A structural feature-based computational approach for toxicology predictions","volume":"6","author":"Valerio","year":"2010","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.taap.2012.03.001_bb0225","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0378-4274(95)03358-R","article-title":"The new chemicals process at the Environmental Protection Agency (EPA): structure\u2013activity relationships for hazard identification and risk assessment","volume":"79","author":"Wagner","year":"1995","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.taap.2012.03.001_bb0230","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.drudis.2006.10.005","article-title":"Similarity-based virtual screening using 2D fingerprints","volume":"11","author":"Willett","year":"2006","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.taap.2012.03.001_bb0240","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/10629360601054255","article-title":"The role of the European Chemicals Bureau in promoting the regulatory use of (Q)SAR methods","volume":"18","author":"Worth","year":"2007","journal-title":"SAR QSAR Environ. Res."},{"key":"10.1016\/j.taap.2012.03.001_bb0235","series-title":"JRC Scientific and Technical Reports","first-page":"1","article-title":"The Applicability of Software Tools for Genotoxicity and Carcinogenicity Prediction: Case Studies relevant to the Assessment of Pesticides","author":"Worth","year":"2010"},{"issue":"Suppl. 9","key":"10.1016\/j.taap.2012.03.001_bb0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/em.2860090602","article-title":"Salmonella mutagencity tests: III. Results from the testing of 255 chemicals","volume":"9","author":"Zeiger","year":"1987","journal-title":"Environ. Mol. Mutagen."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X12000944?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X12000944?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,4]],"date-time":"2020-07-04T00:05:56Z","timestamp":1593821156000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X12000944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S0041008X12000944"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2012.03.001","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}